Alireza Azimi相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Ethnomedicine Knowledge Among Iranian Patients With Gastrointestinal And Liver Disorders: A Cross-Sectional Study

伊朗胃肠道和肝脏疾病患者的民族医学知识：一项横断面研究

期刊:Current Therapeutic Research-Clinical and Experimental

影响因子:1.5

doi:10.1016/j.curtheres.2024.100774

Hasheminasab, Fatemeh Sadat; Zamanian, Yasaman; Haji-Maghsoudi, Saiedeh; Bakhshipour, Alireza; Azimi, Maryam

发表日期：2025

文献求助收藏

Automated assessment of the smoothness of retinal layers in optical coherence tomography images using a machine learning algorithm

利用机器学习算法自动评估光学相干断层扫描图像中视网膜层的平滑度

期刊:BMC Medical Imaging

影响因子:3.2

doi:10.1186/s12880-023-00976-w

Saeidian, Jamshid; Mahmoudi, Tahereh; Riazi-Esfahani, Hamid; Montazeriani, Zahra; Khodabande, Alireza; Zarei, Mohammad; Ebrahimiadib, Nazanin; Jafari, Behzad; Afzal Aghaei, Alireza; Azimi, Hossein; Khalili Pour, Elias

发表日期：2023

文献求助收藏

Surface protein profiling of prostate-derived extracellular vesicles by mass spectrometry and proximity assays

通过质谱和邻近分析对前列腺衍生的细胞外囊泡进行表面蛋白分析

期刊:Communications Biology

影响因子:5.2

doi:10.1038/s42003-022-04349-x

Ehsan Manouchehri Doulabi #, Claudia Fredolini #, Radiosa Gallini, Liza Löf, Qiujin Shen, Ryoyo Ikebuchi, Louise Dubois, Alireza Azimi, Olivier Loudig, Susanne Gabrielsson, Ulf Landegren, Anders Larsson, Jonas Bergquist, Masood Kamali-Moghaddam

细胞生物学

发表日期：2022

文献求助收藏

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma

PTENP1-AS 导致 BRAF 抑制剂耐药性，并与 III 期黑色素瘤的不良临床结果相关

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-021-89389-9

Linda Vidarsdottir, Alireza Azimi, Ishani Das, Ingibjorg Sigvaldadottir, Aldwin Suryo Rahmanto, Andreas Petri, Sakari Kauppinen, Christian Ingvar, Göran Jönsson, Håkan Olsson, Marianne Frostvik Stolt, Rainer Tuominen, Olle Sangfelt, Katja Pokrovskaja Tamm, Johan Hansson, Dan Grandér, Suzanne Egyházi

发表日期：2021

文献求助收藏

Wound healing properties and antimicrobial activity of platelet-derived biomaterials

血小板衍生生物材料的伤口愈合特性和抗菌活性

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-020-57559-w

Shariati, Aref; Moradabadi, Alireza; Azimi, Taher; Ghaznavi-Rad, Ehsanollah

发表日期：2020

文献求助收藏

Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib

CEBPB-AS1 的沉默会调节 CEBPB 表达并使 BRAF 抑制剂耐药黑色素瘤细胞对维莫非尼重新敏感

期刊:Melanoma Research

影响因子:1.5

doi:10.1097/CMR.0000000000000675

Linda Vidarsdottir, Rita Valador Fernandes, Vasilios Zachariadis, Ishani Das, Elin Edsbäcker, Ingibjorg Sigvaldadottir, Alireza Azimi, Veronica Höiom, Johan Hansson, Dan Grandér, Suzanne Egyházi Brage, Katja Pokrovskaja Tamm

发表日期：2020

文献求助收藏

Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma

黑色素瘤中犬尿氨酸通路介导的 CD4+ T 细胞耗竭

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-019-48635-x

Soudabeh Rad Pour, Hiromasa Morikawa, Narsis A Kiani, Muyi Yang, Alireza Azimi, Gowhar Shafi, Mingmei Shang, Roland Baumgartner, Daniel F J Ketelhuth, Muhammad Anas Kamleh, Craig E Wheelock, Andreas Lundqvist, Johan Hansson, Jesper Tegnér

发表日期：2019

文献求助收藏

Enhanced validation of antibodies for research applications

增强抗体验证以用于研究应用

期刊:Nature Communications

影响因子:14.7

doi:10.1038/s41467-018-06642-y

Fredrik Edfors, Andreas Hober, Klas Linderbäck, Gianluca Maddalo, Alireza Azimi, Åsa Sivertsson, Hanna Tegel, Sophia Hober, Cristina Al-Khalili Szigyarto, Linn Fagerberg, Kalle von Feilitzen, Per Oksvold, Cecilia Lindskog, Björn Forsström, Mathias Uhlen

发表日期：2018

文献求助收藏

Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors

靶向 CDK2 可克服黑色素瘤对 BRAF 和 Hsp90 抑制剂的耐药性

期刊:Molecular Systems Biology

影响因子:8.5

doi:10.15252/msb.20177858

Alireza Azimi, Stefano Caramuta, Brinton Seashore-Ludlow, Johan Boström, Jonathan L Robinson, Fredrik Edfors, Rainer Tuominen, Kristel Kemper, Oscar Krijgsman, Daniel S Peeper, Jens Nielsen, Johan Hansson, Suzanne Egyhazi Brage, Mikael Altun, Mathias Uhlen, Gianluca Maddalo

发表日期：2018

文献求助收藏

Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells

沉默 FLI 或靶向 CD13/ANPEP 会导致 EPHA2（BRAF 抑制剂耐药性的介质）去磷酸化，并诱导黑色素瘤细胞生长停滞或凋亡

期刊:Cell Death & Disease

影响因子:8.1

doi:10.1038/cddis.2017.406

Alireza Azimi, Rainer Tuominen, Fernanda Costa Svedman, Stefano Caramuta, Maria Pernemalm, Marianne Frostvik Stolt, Lena Kanter, Pedram Kharaziha, Janne Lehtiö, Carolina Hertzman Johansson, Veronica Höiom, Johan Hansson, Suzanne Egyhazi Brage

发表日期：2017

文献求助收藏